首页> 美国卫生研究院文献>Retrovirology >Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120V3 signatures in the regulation of Co-Receptor usage
【2h】

Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120V3 signatures in the regulation of Co-Receptor usage

机译:HIV-1 B亚型gp41中选定的氨基酸突变与特定gp120V3签名相关共同调节受体的使用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe third variable loop (V3) of the HIV-1 gp120 surface protein is a major determinant of cellular co-receptor binding. However, HIV-1 can also modulate its tropism through other regions in gp120, such as V1, V2 and C4 regions, as well as in the gp41 protein. Moreover, specific changes in gp41 are likely to be responsible for of damage in gp120-CCR5 interactions, resulting in potential resistance to CCR5 inhibitors.In order to genetically characterize the two envelope viral proteins in terms of co-receptor usage, we have analyzed 526 full-length env sequences derived from HIV-1 subtype-B infected individuals, from our and public (Los Alamos) databases. The co-receptor usage was predicted by the analysis of V3 sequences using Geno2Pheno (G2P) algorithm. The binomial correlation phi coefficient was used to assess covariation among gp120V3 and gp41 mutations; subsequently the average linkage hierarchical agglomerative clustering was performed.
机译:背景HIV-1 gp120表面蛋白的第三个可变环(V3)是细胞共受体结合的主要决定因素。但是,HIV-1还可以通过gp120的其他区域(例如V1,V2和C4区域)以及gp41蛋白来调节其向性。此外,gp41的特定变化可能是gp120-CCR5相互作用受损的原因,从而导致了对CCR5抑制剂的潜在耐药性。为了从共同受体的使用角度对两种包膜病毒蛋白进行遗传学表征,我们分析了526来自我们和公共(洛斯阿拉莫斯)数据库的HIV-1 B型亚型感染者的全长env序列。通过使用Geno2Pheno(G2P)算法对V3序列进行分析,可以预测共受体的用法。二项式相关phi系数用于评估gp120V3和gp41突变之间的协变。随后进行平均链接层次聚结聚类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号